指南与共识妇科产科

遗传性癌症综合征与风险评估:ACOG委员会意见第793号

Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793.
指南 / 共识 · Obstet Gynecol · 2019-01-01

遗传性癌症综合征由遗传性致病变异引起,多呈常染色体显性遗传。妇产科医生应定期进行遗传性癌症风险评估,评估内容包括个人史、家族史、病理及影像报告等。若评估提示风险增高,推荐转诊至癌症遗传学专家或遗传学专业人员。

要点

  • 妇产科医生应定期为患者进行遗传性癌症风险评估。
  • 评估内容包括个人史、家族史、病理及影像报告等。
  • 评估提示风险增高时,推荐转诊至遗传学专家进行进一步评估。

核心结论

  • 遗传性癌症风险评估是识别可能处于某些癌症高风险的患者和家族的关键。
  • 评估应由妇产科医生或其他妇产科保健提供者进行,并应定期更新。
  • 若评估提示遗传性癌症综合征风险增加,推荐转诊至癌症遗传学专家或具有遗传学专长的医疗保健提供者。

研究设计与样本

  • 美国妇产科医师学会(ACOG)委员会意见,基于专家共识制定。

主要发现

  • 遗传性癌症综合征通常由遗传性致病变异引起,多数呈常染色体显性遗传。
  • 与女性癌症相关的最常见遗传性癌症综合征包括遗传性乳腺癌和卵巢癌综合征、林奇综合征、Li-Fraumeni综合征、Cowden综合征、Peutz-Jeghers综合征和遗传性弥漫性胃癌。
  • 遗传检测目前由个人史、家族史、系谱分析以及某些情况下的风险模型指导,风险模型可能包括病理报告和通过医疗记录、死亡证明或两者确认癌症诊断。

关键数值与推荐

  • 推荐:若遗传性癌症风险评估提示遗传性癌症综合征风险增加,推荐转诊至癌症遗传学专家或具有遗传学专长的医疗保健提供者进行扩展的家族史信息收集、风险评估、教育和咨询。
  • 评估应包括个人和家族史信息,包括病理、影像报告和其他癌症医疗风险因素的评估。
  • 遗传检测前后的咨询是过程的重要组成部分,以讨论任何遗传检测的理由、披露结果、定义其他癌症风险、识别教育需求并在必要时确保转诊以进行持续管理。

临床怎么用

  • 妇产科医生或其他妇产科保健提供者应进行遗传性癌症风险评估,并定期更新。
  • 若评估提示风险增加,推荐转诊至癌症遗传学专家或具有遗传学专长的医疗保健提供者。
  • 转诊后可进行遗传检测和量身定制的癌症筛查或风险降低措施,或两者兼有。
  • 遗传检测前后应提供咨询。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A hereditary cancer syndrome is a genetic predisposition to certain types of cancer, often with onset at an early age, caused by inherited pathogenic variants in one or more genes. Most hereditary cancer syndromes exhibit autosomal dominant inheritance. The most common hereditary cancer syndromes related to women's cancer include hereditary breast and ovarian cancer syndrome, Lynch syndrome, Li-Fraumeni syndrome, Cowden syndrome, Peutz-Jeghers syndrome, and hereditary diffuse gastric cancer. A hereditary cancer risk assessment is the key to identifying patients and families who may be at increased risk of developing certain types of cancer. Assessments should be performed by obstetrician-gynecologists or other obstetric-gynecologic care providers and should be updated regularly. An assessment includes information on personal and family history, including pathology, imaging reports, and evaluation of other medical risk factors for cancer. If a hereditary cancer risk assessment suggests an increased risk of a hereditary cancer syndrome, referral to a specialist in cancer genetics or a health care provider with expertise in genetics is recommended for expanded gathering of family history information, risk assessment, education, and counseling, which may lead to genetic testing and tailored cancer screening or risk reduction measures, or both. Currently, genetic testing is guided by personal history, family history, pedigree analysis and, in some cases, risk models that may include pathology reports and confirmation of cancer diagnoses with medical records, death certificates, or both. Counseling before and after genetic testing is an important part of the process to discuss rationale for any genetic testing, disclose results, define other cancer risks, identify educational needs, and secure referrals if necessary for ongoing management. This revision includes updates related to hereditary breast and ovarian cancer, cascade testing, and referrals to genetics specialists.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hereditary Cancer Syndromes and Risk Assessment: ACOG COMMITTEE OPINION, Number 793. Obstet Gynecol. 2019. PMID: 31764758. doi:10.1097/AOG.0000000000003562

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。